Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin

Carcinogenesis

Volumn 18, Issue 5, 1997, Pages 957-965

  Tanaka, Takuji ^a   Makita, Hiroki ^a   Kawabata, Kunihiro ^a   Mori, Hideki ^a   Kakumoto, Mikio ^b   Satoh, Kumiko ^b   Hara, Akira ^b   Sumida, Takashi ^c   Tanaka, Tsukasa ^d   Ogawa, Hiroshi ^d  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^c Ehime Citrus Res Institute Inc   (Japan)

^d Ehime ken Fruits Growers Coop A   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; BROXURIDINE; CELL MARKER; DIOSMIN; FLAVONOID; HESPERIDIN; INTESTINE ENZYME; ORNITHINE DECARBOXYLASE; POLYAMINE;

ADENOCARCINOMA; ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CANCER PREVENTION; CELL LABELING; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; CRYPT CELL; DRUG EFFECT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; AZOXYMETHANE; COLONIC NEOPLASMS; DIOSMIN; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; HESPERIDIN; INTESTINAL MUCOSA; MALE; ORGAN SIZE; ORNITHINE DECARBOXYLASE; POLYAMINES; RATS; RATS, INBRED F344;

EID: 0031417008     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.5.957     Document Type: Article

References (69)

1. Shike, M., Winawer, S.J., Greenwald, P.H., Bloch, A., Hill, M.J. and Swaroop, S.V. (1990) Primary prevention of colorectal cancer: the WHO Collaborating Centre for Prevention of Colorectal Cancer. Bull. World Health Organ., 68, 377-385.
2. Weisburger, J.H. (1991) Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids. Am. J. Clin. Nutr., 53, 226S-237S.
3. Boyle, P., Zaridze, D.G. and Smans, M. (1985) Descriptive epidemiology of colorectal cancer. Int. J. Cancer, 38, 9-18.
4. Willett, W.C. (1989) The search for the causes of breast and colon cancer. Nature, 338, 389-394.
5. Reddy, B.S. (1986) Diet and colon cancer: evidence from human and animal model studies. In Reddy, B.S. and Cohen, L.A. (eds) Diet, Nutrition and Cancer: A Critical Evaluation. CRC Press, Boca Raton, FL, pp. 47-65.
6. Kelloff, G.J., Boone, C.W., Crowell, J.A., Steele, V.E., Lubet, R. and Sigman, C.C. (1994) Chemopreventive drug development: perspectives and progress. Cancer Epidemiol. Biomarkers Prev., 3, 85-98.
7. Steinmetz, K.A. and Potter, J.D. (1991) Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control, 2, 325-357.
8. Trock, B., Lanza, E. and Greenwald, P. (1990) Dietary fiber, vegetables, and colon cancer: critical review and meta-analyses of the epidemiologic evidence. J. Natl Cancer Inst., 82, 650-661.
9. Willett, W.C. (1994) Micronutrients and cancer risk. [Review]. Am. J. Clin. Nutr., 59, 1162S-1165S.
10. Block, G., Patterson, B. and Subar, A. (1992) Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr. Cancer, 18, 1-29.
11. Willett, W.C., Stampfer, M.J., Colditz, G.A., Rosner, B.A. and Speizer, F.E. (1990) Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N. Engl. J. Med., 323, 1664-1672.
12. Steinmetz, K.A. and Potter, J.D. (1991) Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control, 2, 427-442.
13. Reddy, B.S. (1993) Nutritional factors as modulators of colon carcinogenesis. In Parke, D.V., Ioannides, C. and Walker, R. (eds) Food, Nutrition and Chemical Toxicity. Smith-Gordon/Nishimura, London/ Niigata, pp. 325-336.
14. Tanaka, T., Kawamori, T., Ohnishi, M., Makita, H., Mori, H., Satoh, K. and Hara, A. (1995) Suppression of azoxymethane-induced rat colon carcinogenesis by dietary administration of naturally occurring xanthophylls, astaxanthin and canthaxanthin during the postinitiation phase. Carcinogenesis, 16, 2957-2963.
15. Szarka, C.E., Grana, G. and Engstrom, P. (1994) Chemoprevention of cancer. Curr. Probl. Cancer, 18, 1-80.
16. Dragsted, L.O., Strube, M. and Larsen, J.C. (1993) Cancer-protective factors in fruits and vegetables: biochemical and biological background. Pharmacol. Toxicol., 72(Suppl.), 116-135.
17. Tanaka, T. and Mori, H. (1996) Inhibition of colon carcinogenesis by non-nutritive constituents in foods. J. Toxicol. Pathol., 9, 139-149.
18. Bird, R.P. (1995) Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett., 93, 55-71.
19. McLellan, E.A., Medline, A. and Bird, R.P. (1991) Sequential analysis of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res., 51, 5270-5274.
20. Pretlow, T.P., Barrow, B.J., Ashton, W.S, O'Riordan, M.A., Pretlow, T.G., Jurcisek, J.A. and Stellato, T.A. (1991) Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res., 51, 1564-1567.
21. Pereira, M.A., Barnes, L.H., Rassman, V.L., Kelloff, G.V. and Steele, V.E. (1994) Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. Carcinogenesis, 15, 1049-1054.
22. Corpet, D.E., Stamp, D., Medline, A., Minkin, S., Archer, M.C. and Bruce, W.R. (1990) Promotion of colonic microadenoma growth in mice and rats fed cooked sugar or cooked casein and fat. Cancer Res., 50, 6955-6958.
23. Hirayama, T. (1979) Diet and cancer. Nutr. Cancer, 1, 67-81.
24. Tanaka, T., Makita, H., Ohnishi, M., Hirose, Y., Wang, A., Mori, H., Satoh, K., Hara, A. and Ogawa, H. (1994) Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of β-carotene. Cancer Res., 54, 4653-4659.
25. Tanaka, T., Makita, H., Kawabata, K. et al. (1997) Suppression of N-methyl-N-amylnitrosamine-induced rat esophageal tumorigenesis by dietary diosmin and hesperidin. Carcinogenesis, 18, in press.
26. Tanaka, T., Makita, H., Ohnishi, M. et al. (1997) Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Cancer Res., 57, 246-252.
27. Nogata, Y., Ohta, H., Yoza, K., Berhow, M. and Hasegawa, S. (1994) High-performance liquid chromatographic determination of naturally occurring flavonoids in Citrus with a photodiode-ray detector. J. Chromatogr., 667, 59-66.
28. Galati, E.M., Monforte, M.T., Kirjavainen, S., Forestieri, A.M. and Trovato, A. (1994) Biological effects of hesperidin, a citrus flavonoid. (note I): Antiinflammatory and analgesic activity. Il Farmaco, 49, 709-712.
29. Da Silva Emim, J.A., Oliviera, A.B. and Lapa, A.J. (1994) Pharmacological evaluation of the anti-inflammatory activity of a citrus bioflavonoid. hesperidin, and the isoflavonoids, duartin and claussequinone, in rats and mice. J. Pharm. Pharmacol., 46, 118-122.
30. Lonchampt, M., Guardiola, B., Sicot, N., Bertrand, M., Perdrix, L. and Duhault, J. (1989) Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study. Arzneimittel-Forschung, 39, 882-885.
31. Damon, P., Flandre, O., Michel, F., Perdrix, L., Labrid, C. and Crastes de Paulet, A. (1987) Effect of chronic treatment with a purified flavonoid fraction on inflammatory granuloma in the rat. Study of prostaglandin E2 and F2α and thromboxane B2 release and histological changes. Arzneimittel-Forschung, 37, 1149-1153.
32. Ratty, A.K. and Das, N.P. (1988) Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship. Biochem. Med. Metab. Biol. 39, 69-79.
33. Wall, M.E., Wani, M.C., Hughes, T.J. and Taylor, H. (1990) Plant antimutagens. In Kuroda, Y., Shankel, D.M. and Waters, M.D. (eds) Antimutagenesis and Anticarcinogenesis Mechanisms II. Plenum Press, New York, pp. 61-78.
34. Fujiki, H., Horiuchi, T., Yamashita, K., Hakii, H., Sugamuma, M., Nishino, H., Iwashima, A., Hirata, Y. and Sugimura, T. (1986) Inhibition of tumor promotion by flavonoids. In Cody, V., Middleton, E.J. and Harborne, J.B. (eds) Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships, Allan R. Liss, Inc., New York, pp. 429-330.
35. Boutin, J.A., Meunier, F., Lambert, P.-H., Hennig, P., Bertin, D., Serkiz, B. and Volland, J.-P. (1993) In vivo and in vitro glucuronidation of the flavonoid diosmetin in rats. Drug Metab. Dispos., 21, 1157-1166.
36. Huang, M.-T., Wood, A.W., Newmark, H.L., Sayer, J.M., Yagi, H., Jerina, D.M. and Conney, A.H. (1983) Inhibition of the mutagenicity of bay-region diolepoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids. Carcinogenesis, 4, 1631-1637.
37. Reddy, B.S. (1992) Inhibitors of the arachidonic acid cascade and their chemoprevention of colon carcinogenesis. In Wattenberg, L., Lipkin, M., Boone, C.W. and Kelloff, G.J. (eds) Cancer Chemoprevention. CRC Press, Boca Raton, FL, pp. 153-164.
38. Marnett, L.J. (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52, 5575-5589.
39. Ward, J.M. (1974) Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab. Invest., 30, 505-513.
40. Hard, C.C. and Butler, W.H. (1970) Cellular analysis of renal neoplasia: induction of renal tumors in dietary-conditioned rats by dimethylnitrosamine with a reappraisal of morphological characteristics. Cancer Res., 30, 2796-2805.
41. Tanaka, T., Kojima, T., Suzui, M. and Mori, H. (1993) Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Cancer Res., 53, 3908-3913.
42. Koide, T. (1992) The clinical significance of tissue, blood and urine polyamine in renal cell carcinoma (in Japanese). Japan. J. Urol., 83, 1228-1237.
43. Koide, T., Sakai, S., Takeda, A., Doi, T., Tei, K., Hara, A. and Sawada, H. (1986) Detection of polyamines by a new enzymatic differential assay. (4) Fundamental study on a new enzymatic differential assay of blood (in Japanese). Acta Urol. Japan., 32, 913-917.
44. Pretlow, T.P, O'Riordan, M.A., Somich, G.A., Amini, S.B. and Pretlow, T.G. (1992) Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis, 13, 1509-1512.
45. Hardman, W.E. and Cameron, I.L. (1996) Letter to the Editor. Carcinogenesis, 17, 1539-1540.
46. Wattenberg, L.W. (1985) Chemoprevention of cancer. Cancer Res., 45, 1-8.
47. Mori, H., Tanaka, T., Sugie, S. and Yoshimi, N. (1995) Chemopreventive effects of plant derived phenolic, organosulfur and other compounds on carcinogenesis in digestive organs. Environ. Mutat. Res. Commun., 15, 127-133.
48. Hebby, O. (1981) Role of polyamines in the control of cell proliferation and differentiation. Differentiation, 19, 1-20.
49. Takano, S., Matsushima, M., Erturk, E. and Bryan, G.T. (1981) Early induction of rat colonic epithelia ornithine and S-adenosyl-1-methionine decarboxylase activities by N-methyl-N′-nitro-N-nitrosoguanidine of bile salts. Cancer Res., 41, 624-628.
50. Pegg, A.E. (1988) Polyamine metabolism and its importance in neoplastic growth as a target for chemotherapy. Cancer Res., 48, 759-774.
51. Luk, G.D., Hamilton, S.R., Yang, P., Smith, J.A. and O'Ceallaigh, D. (1986) Kinetic changes in mucosal ornithine decarboxylase activity during azoxymethane-induced colonic carcinogenesis in the rat. Cancer Res., 46, 235-245.
52. Lipkin, M. (1988) Biomarkers of increased susceptibility to gastrointestinal cancer: new applications to studies of cancer prevention in human subjects. Cancer Res., 48, 235-245.
53. Hixson, L.J., Emerson, S.S., Shassetz, L.R. and Gerner, E.W. (1994) Sources of variability in estimating ornithine decarboxylase activity and polyamine contents in human colorectal mucosa. Cancer Epidemiol. Biomark. Prev., 3, 317-323.
54. Elitsur, Y., Moshier, J.A., Murthy, R., Barbish, A. and Luk, G.D. (1992) Polyamine levels, ornithine decarboxylase (ODC) activity, and ODC-mRNA expression in normal and cancerous human colonocytes. Life Sci., 50, 1417-1424.
55. Meyskens, F.L.J. and Gerner, E.W. (1995) Development of difluoromethylornithine as a chemopreventive agents for the management of colon cancer. J. Cell Biochem., 22(Suppl.), 126-131.
56. Cohen, S.M. and Ellwein, L.B. (1990) Cell proliferation in carcinogenesis. Science, 249, 1007-1011.
57. Tanaka, T., Kojima, T., Hara, A., Sawada, H. and Mori, H. (1993) Chemoprevention of oral carcinogenesis by D,L-α-difluoromethylornithine, an ornithine decarboxylase inhibitor: dose-dependent reduction in 4-nitroquinoline 1-oxide-induced tongue neoplasms in rats. Cancer Res., 53, 772-776.
58. Tanaka, T., Ohnishi, M., Kojima, T., Mori, H., Satoh, K. and Hara, A. (1995) Chemoprevention of N-methyl-N-nitrosourea-induced rat glandular stomach carcinogenesis by a natural product-protocatechuic acid. Cancer J., 8, 150-156.
59. DeRubertis, F.R., Craven, P.A. and Saito, R. (1984) Bile salt stimulation of colonic epithelial proliferation: evidence for the involvement of lipoxygenase products. J. Clin. Invest., 74, 1614-1624.
60. Narisawa, T., Satoh, M., Sano, M. and Takahasji, T. (1983) Inhibition of initiation and promotion of N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroidal anti-inflammatory agent indomethacin. Carcinogenesis, 4, 1225-1227.
61. Eberhart, C.E., Coffey, R.J., Radhika, A., Giardiello, F.M., Ferrenbach, S. and Dubois, R.N. (1994) Up-regulation of cyclooxygenase gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
62. Sano, H., Kawahito, Y., Wilder, R.L. et al. (1995) Expression of cyclooxygenase-1 and 2 in human colorectal cancer. Cancer Res., 55, 3785-3789.
63. Deschner, E.E., Ruperto, J., Wong, G. and Newmark, H.L. (1991) Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis, 12, 1193-1196.
64. Rao, C.V., Simi, B. and Reddy, B.S. (1993) Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis, 14, 2219-2225.
65. Boolbol, S.K., Dannenberg, A.J., Chadburn, A. et al. (1995) Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56, 2556-2560.
66. Labrid, C. (1994) Pharmacologic properties of Daflon 500 mg. Angiology, 45, 524-530.
67. Arcos, J.C. and Argus, M.F. (1995) Multifactor interaction network of carcinogenesis - A 'Tour Guide'. In Arcos, J.C., Argus, M.F. and Woo, Y.-T. (eds) Chemical Induction of Cancer: Modulation and Combination Effects: An Inventory of the Many Factors Which Influence Carcinogenesis. Birkhauser, Boston, pp. 1-20.
68. Qureshi, A., Gorey, T.F., Byrne, P., Kay, E., McKeever, J. and Hennessy, T.P.J. (1994) Oxygen free radical activity in experimental colonic carcinoma. Br. J. Surg., 81, 1058-1059.
69. Meyer, O.C. (1994) Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease. Angiology, 45, 579-584.